• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Vivasure Medical

Vivasure wins CE mark for PerQseal Elite vascular closure system

April 22, 2025 By Sean Whooley

Vivasure Medical announced today that it received CE mark approval for its PerQseal Elite vascular closure system. Galway, Ireland-based Vivasure designed the latest-generation PerQseal Elite for percutaneous vessel closure. It leverages the legacy platform’s safety profile and ease of use while allowing for faster delivery. The system improves performance in calcium and the treatment of […]

Filed Under: Cardiac Implants, Cardiovascular, Regulatory/Compliance, Structural Heart, Vascular Tagged With: Vivasure, Vivasure Medical

The biggest cardiovascular tech stories from TCT 2024

November 1, 2024 By Sean Whooley

The 2024 edition of the Transcatheter Cardiovascular Therapeutics (TCT) conference once again highlighted significant innovations in cardiovascular care. This year’s event in Washington, D.C., featured company updates on all types of technologies, including heart valves, access and closure devices, drug-eluting implants, intravascular lithotripsy (IVL), renal denervation (RDN) and more. Some of the biggest names in […]

Filed Under: Artificial Intelligence (AI), Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Drug-Eluting Stents, Featured, Health Technology, Implants, Machine Learning (ML), Replacement Heart Valves, Software / IT, Stents, Structural Heart Tagged With: Abiomed, Boston Scientific, cardiawave, Edwards Lifesciences, Elixir Medical, HeartFlow, Inari Medical, Johnson & Johnson, Johnson & Johnson MedTech, Medtronic, MitrAssist Medical, nitinol, Shockwave Medical, TCT 2024, Vivasure Medical

Vivasure reports positive PerQseal closure device study results

October 29, 2024 By Sean Whooley

Vivasure Medical reported positive data from an FDA investigational device exemption (IDE) pivotal study evaluating its PerQseal closure device system. Initial results came from the PATCH pivotal study evaluating the safety and efficacy of PerQseal. Investigators presented findings at Transcatheter Cardiovascular Therapeutics (TCT) 2024 in Washington, D.C. Galway, Ireland-based Vivasure designed the latest-generation PerQseal Elite […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Structural Heart, Vascular Tagged With: TCT 2024, Vivasure, Vivasure Medical

Vivasure treats first patients with percutaneous vessel closure device

December 12, 2023 By Sean Whooley

Vivasure Medical announced today that the first patient received treatment with its PerQseal Elite large-hole closure system. Galway, Ireland-based Vivasure designed the latest-generation PerQseal Elite for percutaneous vessel closure. It leverages the legacy platform’s safety profile and ease of use while allowing for faster delivery. The new system also improves performance in calcium and the […]

Filed Under: Cardiovascular, Clinical Trials, Implants, Structural Heart, Surgical, Vascular Tagged With: Vivasure Medical

Vivasure wins FDA IDE approval, receives €30M from Haemonetics

March 13, 2023 By Sean Whooley

Vivasure Medical announced today that it received FDA investigational device exemption (IDE) to advance a clinical study of its PerQseal device. Additionally, Galway, Ireland-based Vivasure announced a €30 million ($32.2 million) investment from Haemonetics. It marks part of the company’s Series D financing, for which the initial $23 million tranche closed in May 2022. The […]

Filed Under: Business/Financial News, Funding Roundup, Implants, Mergers & Acquisitions, Vascular, Wall Street Beat Tagged With: Vivasure, Vivasure Medical

Vivasure raises $23M initial Series D tranche; could reach up to $54M

May 17, 2022 By Sean Whooley

Vivasure Medical announced today that it closed the first tranche — worth $23 million — of its Series D financing round. Galway, Ireland-based Vivasure’s $23 million (€22 million) fundraising tranche could make up a chunk of the Series D that could reach up to $54 million (€52 million) in total. According to a news release, […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Funding Roundup, News Well, Replacement Heart Valves, Structural Heart, Surgical, Vascular Tagged With: Vivasure, Vivasure Medical

Vivasure treats first patient in U.S. study for next-gen PerQseal+ in TAVR procedures

March 15, 2022 By Sean Whooley

Vivasure Medical announced today that the first patient was treated in a U.S. early feasibility study of its next-generation PerQseal+ device. Galway, Ireland-based Vivasure’s study will evaluate PerQseal+ in percutaneous transcatheter aortic valve replacement (TAVR) procedures. The first patient was treated by Dr. Robert Pyo at Stony Brook University Hospital in Stony Brook, New York. […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Replacement Heart Valves, Structural Heart, Vascular Tagged With: Vivasure, Vivasure Medical

Vivasure Medical initiates development of sutureless venous closure device

July 15, 2021 By Sean Whooley

Vivasure Medical announced today that it launched a development program for its PerQseal Blue investigational product. Galway, Ireland-based Vivasure designed PerQseal Blue for sutureless and fully absorbable large-bore venous vessel closure following percutaneous cardiovascular procedures, including transcatheter mitral valve repair/replacement (TMVR) and transcatheter tricuspid valve repair/replacement (TTVR). According to a news release, the company based […]

Filed Under: Business/Financial News, Cardiovascular, Replacement Heart Valves, Research & Development, Structural Heart, Surgical Tagged With: Vivasure Medical

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy